In This Article:
-
Fee Eligible Assets Raised: Over $118 billion since IPO.
-
Total Disposals: $1.3 billion, representing a 40% premium to carrying value.
-
Acquisitions: $1.2 billion in acquisitions, including $330 million stake in Fraser Healthcare Partners.
-
Capital Returned to Shareholders: Approximately $1.2 billion, including a $151 million special dividend.
-
Distributable Earnings Growth: 11% year-on-year increase to $323 million.
-
Adjusted Earnings Per Share: $0.197, 12% higher than 2023.
-
Fee Paying AUM Growth: Increased by 8% year-on-year.
-
Gross Management Fees: $395 million, up 11% year-on-year.
-
Partner Fee Related Earnings (FRE): Increased by 11% to $225 million.
-
Partner Realized Performance Revenues: $73 million, up 33% year-on-year.
-
Net Asset Value Per Share: $4.71, up 9% year-on-year.
-
Total Capital Return in 2024: $563 million, including a proposed final dividend of $0.105 per share.
-
2025 FRE Guidance: Expected between $180 million and $210 million.
Release Date: March 31, 2025
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Positive Points
-
Petershill Partners PLC (LSE:PHLL) reported strong earnings momentum with double-digit growth in distributable earnings, driven by continued growth in fee-paying AUM.
-
The company successfully completed several value-enhancing acquisitions and disposals, generating significant premiums over carrying values.
-
Petershill Partners PLC returned approximately $1.2 billion in capital to shareholders, including a $151 million special dividend, showcasing effective capital management.
-
The companys partner firms raised $32 billion in fee-eligible assets, exceeding guidance and demonstrating resilience in a challenging asset-raising environment.
-
Petershill Partners PLC's partner firms delivered robust investment performance, with an average net IRR of around 17%, outperforming benchmarks by approximately 400 basis points.
Negative Points
-
The industry asset-raising environment remained challenging, with a 21% decline in asset raising year-on-year, marking the third consecutive year of lower asset raising.
-
Deal value in 2024 declined by about 13%, indicating fewer mega-cap deals being executed, which could impact future growth opportunities.
-
Realized investment income was lower compared to the previous year, reflecting the impact of the sale of certain balance sheet exposures.
-
The company faces ongoing economic and geopolitical uncertainty, which could present challenges and slow momentum in the near term.
-
Despite strong asset-raising performance, the overall industry environment remains uncertain, impacting the pace of recovery in industry deal activity.